Cita APA

Eggermont, A. M., Blank, C., Mandala, M., Long, G. V., Atkinson, V., Dalle, S., . . . Robert, C. (2018). Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma.

Citación estilo Chicago

Eggermont, Alexander Maximiliaan, et al. Adjuvant Pembrolizumab Versus Placebo in Resected Stage III Melanoma. 2018.

Cita MLA

Eggermont, Alexander Maximiliaan, et al. Adjuvant Pembrolizumab Versus Placebo in Resected Stage III Melanoma. 2018.